Boundless Bio Makes $100M IPO Debut on Nasdaq
Precision oncology company Boundless Bio is set to go public with a $100 million IPO on the Nasdaq, trading under ...
- Latest
- Trending
Precision oncology company Boundless Bio is set to go public with a $100 million IPO on the Nasdaq, trading under ...
Moleculin Biotech's stock has been given a "sell" rating by a firm, with a 1-year low of $4.34 and a ...
National Gas is partnering with government stakeholders, regulators, and industrial partners to future-proof the energy system. Results from their initiative ...
Eco Wave Power Global AB (publ) is a wave energy company facing financial challenges, yet offers growth potential with innovative ...
NextCure, Inc. (NXTC) is a biopharmaceutical company focused on novel immunomedicines. Strong financials, positive outlook, and promising pipeline.
Texas is a leading innovator, home to NASA, Texas Instruments, and Dell. With a growing economy, teacher shortages, and an ...
Adial Pharmaceuticals, Inc. - A biopharmaceutical company focusing on addiction therapeutics. Stock faced challenges this year, with price drops. Leadership ...
Discover the financial report of Theratechnologies Inc., a biopharmaceutical company specializing in healthcare therapies. Learn about their market cap, leadership ...
Shield revenue increased by 37% YoY, despite a decrease in consulting revenue. Q4 2023 misses revenue by $0.1 million compared ...
Adobe stock wavered in morning trades, but investors are advised to be patient as the company has more generative AI ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.